pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,575 catalysts · 6,271 phase readout · 2,298 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 27 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,271
  • 8k filing2,298
  • earnings390
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT04469686: Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Sponsor: Cristcot HCA LLC. Phase: PHASE3. Conditions: Ulcerative Proctitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06387186: Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy

Sponsor: Elizabeth Anne Thiele. Phase: PHASE1. Conditions: Refractory Epilepsy, Drug Resistant Epilepsy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07489573: Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals. Phase: PHASE4. Conditions: Hidradenitis Suppurativa (HS)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05524883: Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Sponsor: Dyne Therapeutics. Phase: PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07615569: Robot-assisted Versus Conventional Physical Therapy for Hand in Sub-acute Stroke

Sponsor: Montiha Azeem. Phase: NA. Conditions: Stroke, Spastic Hemiplegia, Upper Limb Motor Impairment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07416669: Death, Dying, Violence and Aggression as Shown on Medical Television Series.

Sponsor: King's College Hospital NHS Trust. Phase: . Conditions: End of Life Care, Violent Aggressive Behavior, Television Viewing, Media Use

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04430569: Pulmonary Embolism International THrOmbolysis Study-3

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Pulmonary Embolism

full page →ctgov ↗
›RECRUITINGphase readoutNCT05354869: Transvaginal Electrical Stimulation for Myofascial Pelvic Pain

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Myofascial Pelvic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06544083: Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine. Phase: . Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT02560883: Hairy Cell Leukemia Patient Data Registry

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: . Conditions: Leukemia, Other

full page →ctgov ↗
›COMPLETEDphase readoutNCT07186283: Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers

Sponsor: NW PharmaTech Ltd. Phase: PHASE1. Conditions: PK in Healthy Volunteers

full page →ctgov ↗
›TERMINATEDphase readoutNCT03939169: The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP)

Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: NA. Conditions: Premature Infant

full page →ctgov ↗
›WITHHELDphase readoutNCT06210841: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›COMPLETEDphase readoutNCT00944541: Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis. Phase: PHASE2. Conditions: HIV Infection, HIV Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT07001241: Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Cancer-related Fatigue, Breast Cancer, Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07492173: Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

Sponsor: Shandong New Time Pharmaceutical Co., LTD. Phase: NA. Conditions: Solid Tumor Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06981169: PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults

Sponsor: Université de Sherbrooke. Phase: . Conditions: Asthma, Inflammation, Asthma in Children

full page →ctgov ↗
›COMPLETEDphase readoutNCT07645183: Advanced Technology for Myopia Control in Children and Young Adults

Sponsor: University of Faisalabad. Phase: NA. Conditions: Myopia (Disorder), Refraction Error

full page →ctgov ↗
›RECRUITINGphase readoutNCT05895383: Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy

Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE4. Conditions: Procedural Pain, Pain Catastrophizing, Procedural Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT07217769: Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Shift Work

full page →ctgov ↗
›RECRUITINGphase readoutNCT06571669: BOOM-IBD2 Pivotal Clinical Trial

Sponsor: Boomerang Medical. Phase: NA. Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07492641: BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

Sponsor: BeOne Medicines. Phase: PHASE3. Conditions: HR+/HER2- Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05608083: HEARTS R34 Feasibility Study, Autistic Participants

Sponsor: Boston University Charles River Campus. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03619083: Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07749469: Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin

Sponsor: USMARI Research & Innovation Centre. Phase: NA. Conditions: Acne

full page →ctgov ↗
›RECRUITINGphase readoutNCT06651983: Association of Inflammatory Factors With Complications in the Diabetic Population: a Cross-sectional Study

Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05797441: Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD, Post Traumatic Stress Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT05713669: Impact of Resident Participation in Post-ICU Follow Up Clinic

Sponsor: University of Michigan. Phase: NA. Conditions: Professional Burnout

full page →ctgov ↗
›RECRUITINGphase readoutNCT07597083: Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors

Sponsor: Beni-Suef University. Phase: NA. Conditions: Cervical Cancer, Female Sexual Dysfunction (FSD), Radiation Induced Pelvic Floor Muscle Dysfunction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07376083: Ultrasound vs Chest X-ray for NG Tube Placement in ICU

Sponsor: Tepecik Training and Research Hospital. Phase: . Conditions: Intensive Care (ICU)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07660341: SAD Study of CGB3002 in Healthy Participants

Sponsor: ChainGen Biopharma Ltd. Phase: PHASE1. Conditions: Alzheimer s Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05690841: FocaL Mass Drug Administration for Vivax Malaria Elimination

Sponsor: University of California, San Francisco. Phase: PHASE3. Conditions: Plasmodium Vivax Malaria, Malaria

full page →ctgov ↗
›RECRUITINGphase readoutNCT05822141: Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure

Sponsor: Indiana University. Phase: NA. Conditions: Cold Exposure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07296341: HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Locally Advanced or Metastatic Pancreatic Cancer With

full page →ctgov ↗
›COMPLETEDphase readoutNCT07204483: Feasibility Trial of Functional Clothing, Moderate Exercise, and Health Information for Stress Reduction and Behavior Change in Okinawa

Sponsor: Shinyu Kise. Phase: NA. Conditions: Obesity, Metabolic Syndrome, Stress, Psychological

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07707583: Heart Rate Variability and Medication Adherence in Resistant Hypertension

Sponsor: Nemocnice AGEL Trinec-Podlesi a.s.. Phase: . Conditions: Resistant Hypertension, Medication Adherence, Autonomic Nervous System

full page →ctgov ↗
›COMPLETEDphase readoutNCT03652441: Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

Sponsor: University of Cologne. Phase: PHASE2. Conditions: Classical Hodgkin Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05296954: Localization of Anatomical Structures Involved in Nodal Tachycardias by High Density Mapping.

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Atrioventricular Nodal Reentry Tachycardia, Supraventricular Tachycardia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06255041: Detection of Cancer in Breath Samples by Trained Detection Dogs

Sponsor: SpotitEarly. Phase: . Conditions: Breast Cancer, Colorectal Cancer, PROSTATE CANCER, Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05515354: Smoking Cessation and Menstrual Cycle Phase

Sponsor: Centre for Addiction and Mental Health. Phase: PHASE4. Conditions: Nicotine Dependence, Tobacco Smoking, Smoking Cessation, Nicotine Use Disorder, Substance Use Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT03343769: Study of the Relationship Between the Strength of Ankle Movement Muscles and Postural Parameters in Elderly Fallers: Towards New Strategies for Screening and Management

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Persons Who Have Experienced a Sudden Uncontrolled Fall in the Absence of Outside Factors in the 6 Months Preceding the Consultation

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06940869: Network to Understand Reproductive Rheumatology Registry

Sponsor: Duke University. Phase: . Conditions: Rheumatic Diseases, Pregnancy Related, Pregnancy Interest, Reproductive Health, Autoimmune Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07397273: Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.

Sponsor: Northern Illinois University. Phase: NA. Conditions: Healthy Adult Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04792073: Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Merkel Cell Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04071769: Genentech Xenon MRI Idiopathic Pulmonary Fibrosis

Sponsor: Duke University. Phase: PHASE2. Conditions: Idiopathic Pulmonary Fibrosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03266783: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Sponsor: Ottawa Hospital Research Institute. Phase: PHASE4. Conditions: Venous Thromboembolism

full page →ctgov ↗
›COMPLETEDphase readoutNCT03376269: HBOT Effect on Chronic Pain Syndrome With a History of Psychological Trauma

Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Fibromyalgia, Chronic Pain Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07558070: Effect of Teach-Back-Based Discharge Education in Lower Extremity Surgery Patients

Sponsor: University of Gaziantep. Phase: NA. Conditions: Lower Extremity Surgery, Patient Education, Postoperative Care

full page →ctgov ↗
›RECRUITINGphase readoutNCT07479173: Effects of P24 on Postprandial Aminoacidemia

Sponsor: Amplifye. Phase: NA. Conditions: Postprandial Amino Acid Concentrations in Healthy Adults

full page →ctgov ↗
›RECRUITINGphase readoutNCT02328573: The Impact of Group Singing on Patients With Stroke and Their Personal Caregivers

Sponsor: Icahn School of Medicine at Mount Sinai. Phase: NA. Conditions: Stroke and Aphasia

full page →ctgov ↗
← prev
page 167 of 172
next →